Conditioned Medium from Muramyl Dipeptide-Primed Mesenchymal Stem Cells Enhances Therapeutic Efficacy in Experimental Rheumatoid Arthritis.
Year: 2026
Type: article
Source: PubMed
Institution: Urmia University
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7166532425
FWCI:
Cites:
Cited by:
Related to: